首页> 美国卫生研究院文献>BMC Gastroenterology >Uneven acute non-alcoholic fatty change of the liver after percutaneous transhepatic portal vein embolization in a patient with hilar cholangiocarcinoma – a case report
【2h】

Uneven acute non-alcoholic fatty change of the liver after percutaneous transhepatic portal vein embolization in a patient with hilar cholangiocarcinoma – a case report

机译:肝门部胆管癌患者经皮经肝穿刺门静脉栓塞后肝脏的急性非酒精性脂肪变化不均匀–病例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPortal vein embolization is essential for patients with biliary cancer who undergo extended hepatectomy to induce hypertrophy of the future remnant liver. Over 830 patients have undergone the portal vein embolization at our institution since 1990. Non-alcoholic fatty liver disease is an entity of hepatic disease characterized by fat deposition in hepatocytes. It has a higher prevalence among persons with morbid obesity, type 2 diabetes, and hyperlipidemia. Neither the mechanism of hepatic hypertrophy after portal vein embolization nor the pathophysiology of non-alcoholic fatty liver disease has been fully elucidated. Some researchers integrated the evident insults leading to progression of fatty liver disease into the multiple-hit hypothesis. Among these recognized insults, the change of hemodynamic status of the liver was never mentioned.
机译:背景技术门静脉栓塞对于胆道癌患者来说是必不可少的,他们需要接受扩大的肝切除术来诱发未来残余肝脏的肥大。自1990年以来,超过830名患者在我们机构接受了门静脉栓塞术。非酒精性脂肪肝是一种以脂肪沉积在肝细胞中为特征的肝病。在病态肥胖,2型糖尿病和高脂血症患者中,它的患病率更高。门静脉栓塞后的肝肥大的机制和非酒精性脂肪肝疾病的病理生理学都尚未完全阐明。一些研究人员将导致脂肪肝疾病进展的明显侮辱现象纳入了多重打击假说中。在这些公认的侮辱中,从未提及肝脏血液动力学状态的改变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号